• Scilex plans to accelerate growth as a public company and further advance its non-opioid therapeutic pain management portfolio to transform the acute and chronic pain ambulatory market
  
• Scilex will ring the Nasdaq opening bell on Friday, November 11, 2022 at 9:30 am ET. Watch the ceremony live on Nasdaq Live broadcast

PALO ALTO, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. SRNE “Sorrento”))), an innovative, revenue-generating company focused on the acquisition, development and commercialization of non-opioid pain management products for the management of acute and chronic pain, announced that shares of its common stock are trading on the Nasdaq Capital Market will be Friday 11 November 2022 under the ticker symbol “SCLX”. Scilex’s commercial debut follows the completion of its business combination with Vickers Vantage Corp. I, a special purpose acquisition company (the “Business Combination”). The combined company now operates as Scilex Holding Company.

Scilex Holding Company is uncompromisingly striving to become the world’s leading pain management company committed to social, environmental, economic and ethical principles to responsibly develop pharmaceutical products to maximize the quality of life.

Henry Ji, Ph.D., Executive Chairman of Scilex and Chairman and Chief Executive Officer of Sorrento, and Jaisim Shah, President and Chief Executive Officer of Scilex, will attend the ceremony along with other members of the Scilex leadership team and the Scilex Board of Directors Sorrento guide members. “This is an extremely exciting moment for the Scilex team. The ringing of the opening bell on Nasdaq reflects the hard work of our team and celebrates our continued growth,” said Henry Ji, Ph.D. “I am confident and look forward to Scilex’s future growth and journey.”

Scilex Holding Company will ring the Nasdaq opening bell on Friday, November 11, 2022 at 9:30 am ET. Watch the ceremony live on Nasdaq Live broadcast.

About Scilex…